Autophagy as a potential target for sarcoma treatment

Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):40-50. doi: 10.1016/j.bbcan.2017.02.004. Epub 2017 Feb 24.

Abstract

Autophagy is a constitutively active, evolutionary conserved, catabolic process for maintaining homeostasis in cellular stress responses and cell survival. Although its mechanism has not been fully illustrated, recent work on autophagy in various types of sarcomas has demonstrated that autophagy exerts an important role in sarcoma cell growth and proliferation, in pro-survival response to therapies and stresses, and in therapeutic resistance of sarcoma. Thus, the autophagic process is being seen as a possibly novel therapeutic target of sarcoma. Additionally, some co-regulators of autophagy have also been investigated as promising biomarkers for the diagnosis and prognosis of sarcoma. In this review, we summarize contemporary advances in the role of autophagy in sarcoma and discuss the potential of autophagy as a new target for sarcoma treatment.

Keywords: Autophagy; Sarcoma; Targeted cancer therapy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Autophagy / drug effects
  • Autophagy / physiology*
  • Biomarkers, Tumor / metabolism
  • Cell Proliferation / drug effects
  • Cell Proliferation / physiology*
  • Cell Survival / drug effects
  • Humans
  • Sarcoma / drug therapy
  • Sarcoma / metabolism
  • Sarcoma / pathology*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor